Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.87B |
| 2 |
NVIDIA
NVDA
|
+$358M |
| 3 |
Suncor Energy
SU
|
+$287M |
| 4 |
Microsoft
MSFT
|
+$278M |
| 5 |
Apple
AAPL
|
+$200M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.8B |
| 2 |
Canadian Natural Resources
CNQ
|
+$205M |
| 3 |
Intuit
INTU
|
+$177M |
| 4 |
Adobe
ADBE
|
+$120M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$95.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.4% |
| 2 | Financials | 18.68% |
| 3 | Industrials | 9.33% |
| 4 | Healthcare | 8.68% |
| 5 | Communication Services | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
RenaissanceRe
RNR
$13.4B
| $19.6M | 0.01% |
77,288
-1,993
| -3% | -$483K |
|
327
Amkor Technology
AMKR
$13.6B
| $19.5M | 0.01% |
687,918
+65,485
| +11% | +$1.58M |
|
328
Ligand Pharmaceuticals
LGND
$5.84B
| $19.3M | 0.01% |
108,926
+2,860
| +3% | +$425K |
|
329
Edwards Lifesciences
EW
$51.7B
| $19.2M | 0.01% |
247,420
-68,972
| -22% | -$5.39M |
|
330
Sanmina
SANM
$11B
| $19.2M | 0.01% |
+166,861
| New | +$18.8M |
|
331
Worthington Enterprises
WOR
$2.86B
| $19.1M | 0.01% |
343,591
+55,917
| +19% | +$3.52M |
|
332
Wipro
WIT
$19.8B
| $18.9M | 0.01% |
7,197,876
+177,146
| +3% | +$499K |
|
333
Snap-on
SNA
$21.5B
| $18.8M | 0.01% |
54,209
+8,678
| +19% | +$2.84M |
|
334
Ovintiv
OVV
$16.6B
| $18.7M | 0.01% |
463,441
-35,451
| -7% | -$1.45M |
|
335
CONMED
CNMD
$1.46B
| $18.7M | 0.01% |
397,046
+33,725
| +9% | +$1.75M |
|
336
Boston Properties
BXP
$11.1B
| $18.6M | 0.01% |
250,316
+39,682
| +19% | +$2.8M |
|
337
AAR Corp
AIR
$5.77B
| $18.6M | 0.01% |
207,000
-1
| -0% | -$76 |
|
338
Merit Medical Systems
MMSI
$5.3B
| $18.4M | 0.01% |
221,609
+6,164
| +3% | +$537K |
|
339
Fluor
FLR
$7.96B
| $18.4M | 0.01% |
437,164
+121,057
| +38% | +$5.57M |
|
340
Prestige Consumer Healthcare
PBH
$2.61B
| $18.3M | 0.01% |
293,709
-11,917
| -4% | -$830K |
|
341
First Financial Bancorp
FFBC
$3.54B
| $18.2M | 0.01% |
722,400
-48,199
| -6% | -$1.22M |
|
342
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $18M | 0.01% |
765,206
-253,151
| -25% | -$5.9M |
|
343
Materion
MTRN
$6.1B
| $18M | 0.01% |
148,697
+21,529
| +17% | +$2.26M |
|
344
ITT
ITT
$19.3B
| $17.9M | 0.01% |
100,412
-5,453
| -5% | -$915K |
|
345
Berkshire Hathaway Class B
BRK.B
$1.12T
| $17.8M | 0.01% |
35,468
-542
| -2% | -$263K |
|
346
DexCom
DXCM
$31.8B
| $17.7M | 0.01% |
263,564
-23,056
| -8% | -$1.82M |
|
347
Qualys
QLYS
$6.29B
| $17.4M | 0.01% |
131,652
-12,350
| -9% | -$1.67M |
|
348
Trex
TREX
$4.99B
| $17M | 0.01% |
329,124
+52,508
| +19% | +$3.2M |
|
349
Azenta
AZTA
$1.45B
| $16.8M | 0.01% |
586,289
-48,408
| -8% | -$1.5M |
|
350
Tanger
SKT
$4.5B
| $16.7M | 0.01% |
492,568
-12,363
| -2% | -$403K |
|
Similar funds
Ken Fisher's Q3 2025 Portfolio in Review
As of Q3 2025, Ken Fisher held 1,094 positions worth $276B, up 9.7% from $252B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher's Q3 2025 filing shows 108 new, 450 increased, 424 reduced and 80 closed positions. Its largest new stake was Sanmina: 166,861 shares worth $19.2M. The largest sale was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Ken Fisher's largest Q3 2025 buy was Sanmina: 166,861 shares worth $19.2M.
- Ken Fisher added most to iShares 7-10 Year Treasury Bond ETF in Q3 2025, an estimated $2.87B increase.
- Ken Fisher's biggest Q3 2025 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $1.8B.
- Ken Fisher fully exited WEX in Q3 2025, selling an estimated $14.2M.
- Ken Fisher's ten largest holdings make up 32% of its $276B portfolio in Q3 2025.
- Ken Fisher opened 108 new positions and closed 80 in Q3 2025.
- Ken Fisher's portfolio value rose 9.7% quarter-over-quarter to $276B.
Based on Fisher Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.